Navigation Links
Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Date:1/19/2010

CHADDS FORD, Pa., Jan. 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).

The company is currently reviewing the details of this notice from Watson.  Endo intends to vigorously defend LIDODERM's intellectual property rights and pursue all available legal and regulatory pathways in defense of LIDODERM.  

The Paragraph IV certification notice refers to U.S. Patent No. 5,827,529, which covers the formulation of LIDODERM, a topical patch to relieve the pain of postherpetic neuralgia launched in 1999. This patent is listed in the U.S. Food and Drug Administration's (FDA) Orange Book and expires in October 2015.

Citizen Petition

With respect to Endo's regulatory approach, the company submitted a Citizen Petition in 2006 in reaction to a proposal by FDA's Office of Generic Drugs that would diverge from applicable regulations and standards of practice regarding bioequivalence. The company is requesting that the agency reconsider its departure from its longstanding general rule of requiring clinical endpoint bioequivalence studies for locally acting generic drug products, including those that reference LIDODERM.  To ensure the safe and effective equivalence of any generic version to LIDODERM, which acts locally in the skin, Endo believes that FDA must return to its established standard of clinical endpoint bioeq
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... 23, 2013  PAREXEL International Corporation (NASDAQ: ... at the Jefferies Healthcare Conference in New York.  ... Chief Financial Officer, will be making a presentation on ... Monday, June 3, 2013. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:5/22/2013)... , May 22, 2013  Aribex, Inc., manufacturer ... system, today introduced a new color option, black with ... U.S. dental and veterinary markets. The popular white with ... month will continue to be available and both models ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2PAREXEL International To Present At Jefferies Healthcare Conference 2Aribex Unveils New Color of NOMAD Pro 2 2
... 2011  Proventix Systems, Inc., today announced its nGage™ ... hand hygiene monitoring system in the United States.  ... total hand cleansings. Hospitals have experienced ... dispenses since implementation of the Proventix monitoring system. ...
... brings a whole set of skin problems for many people, ... Americans who suffer from psoriasis. Cold weather, dry indoor heat, ... rob the skin of the moisture it needs, causing psoriasis ... system, making it harder for the body to resist psoriasis ...
Cached Medicine Technology:Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 2Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 3PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 2PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 3PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 4
(Date:5/23/2013)... May 23, 2013 NDI Medical, ... and develops innovative neurodevice technologies, has launched its ... DBI will commercialize its groundbreaking technology that ... therapy for patients with Parkinson’s disease. Currently ... disease and generates more than $275 million in ...
(Date:5/23/2013)... PETA International Science Consortium, Ltd., issued the following ... of 2013: , Reform of chemical safety legislation ... testing. , Ensuring the safety and appropriate ... Reforming the EPA,s Toxic Substances Control Act is ... Council,s vision for transforming toxicity testing "from a ...
(Date:5/23/2013)... Dotinga HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay ... scans for detecting lung cancer now have more information to ... U.S. study finds that low-dose CT scans pick up significantly ... a long history of smoking are at high risk for ... States. But doctors have to consider the potential harm of ...
(Date:5/23/2013)... In Florida, residents have not been hit with a ... Florida’s good luck will continue, warns Rick Knabb, Director of ... residents, it is important to prepare as if one could ... to be a 50-percent chance that a major hurricane could ... from June 1 to November 30 in Florida, this makes ...
(Date:5/23/2013)... Award-winning parent coaching and training ... ImpactADHD’s six-part Parent Academy Mastery Series gives families ... challenges of raising ADHD kids head-on. Parenting kids ... frustrating. It can also be joyful and positively ... and the ‘good stuff’ is all-too-often out of ...
Breaking Medicine News(10 mins):Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:New Approach to ADHD Managment Focuses On Parents, Not Kids 2
... while sticking to your diet. Here,s how. , FRIDAY, Dec. 25 ... you,ve eaten and that box of Santa Claus-shaped candies is calling ... overeat and overindulge aren,t over yet. , Before you take one ... to get a handle on your holiday eating. , If you,ve ...
... how product is designed, study shows , THURSDAY, Dec. ... everything from promoting youth violence to contributing to childhood obesity, ... planned on passing by the video game aisle this holiday ... can sharpen certain thinking skills, increasing cognitive speed in those ...
... Dec. 24 Today, The U.S. Conference of Mayors (USCM) congratulates ... health care for millions of the uninsured. In a historic ... the Patient Protection and Affordable Care Act. , "Not ... on Christmas Eve. It is appropriate the most important ...
... THURSDAY, Dec. 24 (HealthDay News) -- Acetaminophen -- best ... physical pain, but a new study suggests that the ... of rejection. , Researchers assigned 62 healthy college undergraduate ... 1,000 milligrams of acetaminophen daily, while the others took ...
... , ... (PhRMA) Senior Vice President Ken Johnson released the following statement ... the Senate for taking an important and historic step toward ... of millions of Americans, many of whom are struggling today ...
... , , WASHINGTON, Dec. 24 ... Senate voted to pass the Patient Protection and Affordable Care ... bill on Christmas Eve, after overcoming a series of procedural ... stop the bill from ever reaching the Senate floor for ...
Cached Medicine News:Health News:Eat Up, But Eat Healthy This Holiday Season 2Health News:Video Games Could Boost Certain Thinking Skills 2Health News:Video Games Could Boost Certain Thinking Skills 3Health News:Tylenol May Ease Headaches and Heartaches 2Health News:Tylenol May Ease Headaches and Heartaches 3Health News:PhRMA Statement on Senate Health Care Reform Bill 2Health News:PhRMA Statement on Senate Health Care Reform Bill 3Health News:DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: